ClinicalTrials.Veeva

Menu

Amlodipine Diabetic Hypertension Efficacy Response Trial (ADHERE)

Viatris logo

Viatris

Status and phase

Completed
Phase 4

Conditions

Hypertension

Treatments

Drug: Amlodipine

Study type

Interventional

Funder types

Industry

Identifiers

NCT00159692
A0531063

Details and patient eligibility

About

To evaluate the percentage of subjects that reach the diabetic hypertensive blood pressure goal of <130/80 with amlodipine versus placebo in subjects initially treated with quinapril or losartan.

Enrollment

739 patients

Sex

All

Ages

30 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Documented evidence of Type 2 diabetes as defined by the ADA guidelines and documented evidence of Hypertension (various SBP/DBP ranges).

Exclusion criteria

  • A previous history or intolerance or hypersensitivity to calcium channel blockers, ARBs or ACE inhibitors.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems